Ioana Berindan-Neagoe logo Academic Members logo

Ioana Berindan-Neagoe

Director of Research Center of Functional Genomics, Biomedicine and Translational Medicine, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)


Prof. Dr Ioana Berindan-Neagoe is a Professor of Medical Biotechnology and the Director of the Research Center for Functional Genomics, Biomedicine, and Translational Medicine at the Iuliu Hatieganu University of Medicine and Pharmacy. She was trained in Functional Genomics at Institut Gustave Roussy under the supervision of Dr Lazar. Also, she was a Visiting Professor in the Department of Experimental Therapeutics at M.D. Anderson Cancer Center and a Fulbright fellow.

She received the Ad Astra Prize in 2018 for being the best scientist in Romania in Life Sciences. She coordinated, during the last 13 years, more than 50 research projects with a total amount of over 13 million euros in equipment, reagents, and personnel.

Among the major research interests are: (a) genomics profiling of tumors for the identification of new biomarkers, (b) drug discovery and drug repurposing, (c) target drug delivery, and (d) tumor microenvironment and spatial biology/spatial transcriptomics of tumors and the response to different drugs.

She published over 350 papers in IF journals with an H-index of 51.

She is a national expert at the European Commission in the Subgroup Cancer.


Why WIN

Developing clinical trials and research projects within the consortium

Ioana Berindan-Neagoe logo

Ioana Berindan-Neagoe

Director of Research Center of Functional Genomics, Biomedicine and Translational Medicine, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)


Academic Members logo

Prof. Dr Ioana Berindan-Neagoe is a Professor of Medical Biotechnology and the Director of the Research Center for Functional Genomics, Biomedicine, and Translational Medicine at the Iuliu Hatieganu University of Medicine and Pharmacy. She was trained in Functional Genomics at Institut Gustave Roussy under the supervision of Dr Lazar. Also, she was a Visiting Professor in the Department of Experimental Therapeutics at M.D. Anderson Cancer Center and a Fulbright fellow.

She received the Ad Astra Prize in 2018 for being the best scientist in Romania in Life Sciences. She coordinated, during the last 13 years, more than 50 research projects with a total amount of over 13 million euros in equipment, reagents, and personnel.

Among the major research interests are: (a) genomics profiling of tumors for the identification of new biomarkers, (b) drug discovery and drug repurposing, (c) target drug delivery, and (d) tumor microenvironment and spatial biology/spatial transcriptomics of tumors and the response to different drugs.

She published over 350 papers in IF journals with an H-index of 51.

She is a national expert at the European Commission in the Subgroup Cancer.


Why WIN

Developing clinical trials and research projects within the consortium